CommercialCoverageLow impact
08.00.51m, Enzyme Replacement for the Treatment of Gaucher's Disease
Independence Blue Cross·Endocrinology, Hematology, Oncology +1 more·Medical Policy
Effective date
Jan 2, 2026
We identified it
Jun 19, 2026
Summary
Policy 08.00.51m regarding enzyme replacement therapy for Gaucher's Disease has been updated for commercial plans. This is a fresh policy update that may contain changes to coverage criteria, prior authorization requirements, or billing guidelines for this specialized treatment.
Action Required
By January 2, 2026: Billing team should review the updated policy 08.00.51m for enzyme replacement therapy for Gaucher's Disease at the provided URL to identify any changes to coverage criteria, prior authorization requirements, or documentation needs. Update billing procedures accordingly for commercial plans.